Drug Shortage Report for SANDOZ CANDESARTAN PLUS

Last updated on 2020-08-24 History
Report ID 73123
Drug Identification Number 02327902
Brand name SANDOZ CANDESARTAN PLUS
Common or Proper name CANDESARTAN PLUS
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL
Strength(s) 12.5MG 16MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-11-01
Estimated end date 2020-08-07
Actual end date 2020-08-03
Shortage status Resolved
Updated date 2020-08-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-01-21 English Compare
v2 2019-01-21 French Compare
v3 2019-01-21 English Compare
v4 2019-01-21 French Compare
v5 2019-01-30 English Compare
v6 2019-01-30 French Compare
v7 2019-02-04 English Compare
v8 2019-02-04 French Compare
v9 2019-02-12 English Compare
v10 2019-02-12 French Compare
v11 2019-02-18 English Compare
v12 2019-02-18 French Compare
v13 2019-03-05 English Compare
v14 2019-03-05 French Compare
v15 2019-03-26 English Compare
v16 2019-03-26 French Compare
v17 2019-04-15 English Compare
v18 2019-04-15 French Compare
v19 2019-06-12 English Compare
v20 2019-06-12 French Compare

Showing 1 to 20 of 42